Becker's ASC Review

12 EXECUTIVE BRIEFING 2 EXECUTIVE BRIEFING SPONSORED BY A successful 2023 starts with ensuring your clinic or ASC has the best DME SaaS technology T here's no question that the past few years have been challenging for the healthcare sector. Now is the time, however, for organizations to look forward and proactively develop plans to support staff, patients, and providers, while also drive for better operating performance. Becker's ASC Review recently spoke with Terry Ross, Enovis™ President of Bracing & Supports, and Mike Edwards, Enovis Vice President of Healthcare Solutions, about the technology and automated software solutions that leading orthopedic clinics and ASCs are adopting to ensure their practices are ready for the future. Leveraging technology to increase patient throughput and deliver positive outcomes Healthcare leaders recognize patients as their most important area of focus. At the same time, however, overseeing business needs like inventory management, reimbursement, price transparency and staff shortages are top priorities. Significant opportunities exist for orthopedic clinics and ASCs to leverage automation to address these issues - but choosing the right solution can be daunting. "The market is saturated with disparate systems and fragmented offerings and making the wrong decision can cost you even more time and money," Mr. Ross said. "Business partners and solutions must solve real problems. The goal is to empower staff to maximize their roles and deliver a clear return." Enovis is the new company name for DJO Global®, the provider of orthopedic solutions like DonJoy® and Aircast® bracing; Altivate® shoulder, EMPOWR™ knee and hip, STAR® ankle devices; and Chattanooga® rehabilitation equipment. Enovis is unique in that it is both a software and a product technology company. It delivers clinically differentiated solutions that generate measurably better patient outcomes and transform workflows across the continuum of care. Enovis' MotionMD® platform streamlines a variety of functions, ranging from patient selection (with OaraScore® risk stratification tool) to inventory management, claims processing, benefits verification (with VeriPro® price transparency), saving time and energy for providers. Safely expanding the number of candidates suitable for outpatient procedures in the ASC Today's patients are highly engaged in their health and wellness. They want to participate actively in decisions about their care and many prefer to have orthopedic procedures in an outpatient setting. To confidently migrate patients to the ASC, providers can use OaraScore, which is part of the Enovis MotionMD platform. OaraScore is a predictive arthroplasty risk-assessment tool that analyzes nine comorbidity cohorts to determine whether a patient is well suited for rapid discharge. Surgeons can evaluate individuals based on issues related to hematology, cardiology, endocrinology, gastroenterology, neurology, renal, urology, pulmonology, and infectious diseases. "By examining multiple aspects of a patient's medical and social history, OaraScore® allows surgeons to safely extend their population for outpatient surgery to a wider group of individuals who may have medical issues, but are stable enough to pursue outpatient surgery," Mr. Edwards said. A retrospective study published in the Journal of Arthroplasty found that OaraScore for primary total joint arthroplasty has more precise predictive ability than either the ASA Physical Status or the Charlson Comorbidity Index. OaraScore is based on an algorithm that improves over time, it is frequently updated to adapt to advancements in medicine. This is a clear advantage over older screening tools which haven't changed since they were first developed decades ago, according to Mr. Edwards. "OaraScore addresses one of the most critical components of a successful outpatient total joint program — patient selection," Mr. Edwards said. Another important consideration is the time required to calculate OaraScore. This assessment tool fits perfectly into preoperative evaluation and assessment workflows. Most surgeons with a healthy patient can complete the scoring in under a minute or two. In addition to presurgical evaluations, OaraScore reminds surgeons when the 90-day period of a patient's postoperative follow-up is complete. Clinicians can enter whether the patient had complications and whether the patient was discharged without a readmission within those 90 days. Within OaraScore, surgeons can track different types of data and compare them to colleagues on a national level.

• Cover